首页> 美国卫生研究院文献>The EMBO Journal >L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1
【2h】

L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1

机译:L1CAM通过NBS1调节胶质母细胞瘤干细胞的DNA损伤检查点反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Glioblastomas (GBMs) are highly lethal brain tumours with current therapies limited to palliation due to therapeutic resistance. We previously demonstrated that GBM stem cells (GSCs) display a preferential activation of DNA damage checkpoint and are relatively resistant to radiation. However, the molecular mechanisms underlying the preferential checkpoint response in GSCs remain undefined. Here, we show that L1CAM (CD171) regulates DNA damage checkpoint responses and radiosensitivity of GSCs through nuclear translocation of L1CAM intracellular domain (L1-ICD). Targeting L1CAM by RNA interference attenuated DNA damage checkpoint activation and repair, and sensitized GSCs to radiation. L1CAM regulates expression of NBS1, a critical component of the MRE11–RAD50–NBS1 (MRN) complex that activates ataxia telangiectasia mutated (ATM) kinase and early checkpoint response. Ectopic expression of NBS1 in GSCs rescued the decreased checkpoint activation and radioresistance caused by L1CAM knockdown, demonstrating that L1CAM signals through NBS1 to regulate DNA damage checkpoint responses. Mechanistically, nuclear translocation of L1-ICD mediates NBS1 upregulation via c-Myc. These data demonstrate that L1CAM augments DNA damage checkpoint activation and radioresistance of GSCs through L1-ICD-mediated NBS1 upregulation and the enhanced MRN–ATM–Chk2 signalling.
机译:胶质母细胞瘤(GBM)是高度致死性的脑瘤,由于治疗耐药性,目前的治疗方法仅限于缓解。我们以前证明了GBM干细胞(GSC)显示出DNA损伤检查点的优先激活,并且相对抗辐射。但是,GSCs中优先检查站响应的分子机制仍然不确定。在这里,我们显示L1CAM(CD171)通过L1CAM细胞内结构域(L1-ICD)的核转运来调节DNA损伤检查点反应和GSC的放射敏感性。通过RNA干扰靶向L1CAM可以减弱DNA损伤检查点的激活和修复,并使GSC对辐射敏感。 L1CAM调节NBS1的表达,NBS1是MRE11–RAD50–NBS1(MRN)复合物的关键成分,可激活共济失调性毛细血管扩张突变(ATM)激酶和早期检查点反应。 NSC1在GSC中的异位表达挽救了由L1CAM敲低引起的减少的检查点激活和放射抵抗,表明L1CAM通过NBS1信号调节DNA损伤检查点反应。从机制上讲,L1-ICD的核易位通过c-Myc介导NBS1上调。这些数据表明,L1CAM通过L1-ICD介导的NBS1上调和增强的MRN–ATM–Chk2信号传导增强了GSC的DNA损伤检查点激活和放射抗性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号